These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Surgery and intravesical chemotherapy in the management of superficial bladder cancer. Soloway MS Semin Urol; 1983 Feb; 1(1):23-33. PubMed ID: 6433424 [No Abstract] [Full Text] [Related]
5. Intravesical chemotherapy in the management of superficial bladder tumors. Schulman CC Prog Clin Biol Res; 1984; 153():275-85. PubMed ID: 6433356 [No Abstract] [Full Text] [Related]
7. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma. Soloway MS; Jordan AM; Murphy WM Prog Clin Biol Res; 1989; 310():215-36. PubMed ID: 2505268 [TBL] [Abstract][Full Text] [Related]
8. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis. Huncharek M; McGarry R; Kupelnick B Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841 [TBL] [Abstract][Full Text] [Related]
10. Intravesical therapy comparing BCG, adriamycin, and thiotepa in 200 patients with superficial bladder cancer: a randomized prospective study. Martinez-Pineiro JA; Jimenez León J; Martinez-Pineiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P Prog Clin Biol Res; 1989; 310():237-52. PubMed ID: 2505269 [TBL] [Abstract][Full Text] [Related]
11. Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder. Hardeman SW; Perry A; Soloway MS J Urol; 1988 Aug; 140(2):289-92. PubMed ID: 3135420 [TBL] [Abstract][Full Text] [Related]
12. Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202 patients with superficial bladder cancer. Martínez-Piñeiro JA; Jiménez León J; Martínez-Piñeiro L; Fiter L; Mosteiro JA; Navarro J; García Matres MJ; Cárcamo P J Urol; 1990 Mar; 143(3):502-6. PubMed ID: 2106041 [TBL] [Abstract][Full Text] [Related]
13. [Progress in the internist treatment of bladder tumors]. Baumgartner G Wien Med Wochenschr; 1982 Jul; 132(13-14):305-12. PubMed ID: 6814073 [TBL] [Abstract][Full Text] [Related]
14. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer. Huben RP Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806 [TBL] [Abstract][Full Text] [Related]
15. Treatment of superficial bladder cancer with intravesical chemotherapy. Badalament RA; Farah RN Semin Surg Oncol; 1997; 13(5):335-41. PubMed ID: 9259089 [TBL] [Abstract][Full Text] [Related]
16. BCG versus thiotepa in non-CIS, stage Ta, T1 bladder cancer: rationale and design of ECOG trial. Fisher HA Prog Clin Biol Res; 1989; 310():275-83. PubMed ID: 2505271 [No Abstract] [Full Text] [Related]
17. The biology and treatment of superficial bladder cancer. Torti FM; Lum BL J Clin Oncol; 1984 May; 2(5):505-31. PubMed ID: 6427417 [TBL] [Abstract][Full Text] [Related]